Complications of sickle cell anaemia in children in Northwestern Tanzania

Hematology

Volumn 21, Issue 4, 2016, Pages 248-256

  Saidi, Hamza ^a   Smart, Luke R ^b,c   Kamugisha, Erasmus ^b   Ambrose, Emmanuela E ^b   Soka, Deogratias ^a   Peck, Robert N ^b,c   Makani, Julie ^a,d  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b WEILL BUGANDO SCHOOL OF MEDICINE   (Tanzania)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acute chest syndrome; Children; Sickle cell anaemia; Stroke; Sub Saharan Africa; Tanzania; Vaso occlusive episode

Indexed keywords

PNEUMOCOCCUS VACCINE; FOLIC ACID;

ACUTE CHEST SYNDROME; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CROSS-SECTIONAL STUDY; DACTYLITIS; DEMOGRAPHY; EVALUATION AND FOLLOW UP; FEMALE; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; LEG ULCER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRESCHOOL CHILD; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SICKLE CELL ANEMIA; TANZANIA; VACCINATION; CLINICAL TRIAL; COMPLICATION; MALARIA; MULTICENTER STUDY; STROKE; VASCULAR DISEASES;

ACUTE CHEST SYNDROME; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; HOSPITALIZATION; HUMANS; MALARIA; MALE; PNEUMOCOCCAL VACCINES; STROKE; TANZANIA; VASCULAR DISEASES;

EID: 84983438748     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245332.2015.1101976     Document Type: Article

References (43)

1. F.B.Piel, A.P.Patil, R.E.Howes, O.A.Nyangiri, P.W.Gething, M.Dewi, Global epidemiology of sickle haemoglobin in neonates:a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142–51. doi:10.1016/S0140-6736(12)61229-X
2. F.B.Piel, S.I.Hay, S.Gupta, D.J.Weatherall, T.N.Williams. Global burden of sickle cell anaemia in children under five, 2010–2050:modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7):e1001484. doi:10.1371/journal.pmed.1001484
3. J.Makani, S.E.Cox, D.Soka, A.N.Komba, J.Oruo, H.Mwamtemi, Mortality in sickle cell anemia in Africa:a prospective cohort study in Tanzania. PLoS One. 2011 Jan;6(2):e14699. doi:10.1371/journal.pone.0014699
4. S.L.Leikin, D.Gallagher, T.R.Kinney, D.Sloane, P.Klug, W.Rida. Mortality in children and adolescents with sickle cell disease. Cooperative study of sickle cell disease. Pediatrics. 1989;84(3):500–8.
5. O.S.Platt, D.J.Brambilla, W.F.Rosse, P.F.Milner, O.Castro, M.H.Steinberg, Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–44. doi:10.1056/NEJM199406093302303
6. P.Telfer, P.Coen, S.Chakravorty, O.Wilkey, J.Evans, H.Newell, Clinical outcomes in children with sickle cell disease living in England:A neonatal cohort in East London. Haematologica. 2007;92(7):905–12. doi:10.3324/haematol.10937
7. C.T.Quinn, Z.R.Rogers, T.L.McCavit, G.R.Buchanan. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115:3447–52. doi:10.1182/blood-2009-07-233700
8. J.Makani, D.Soka, S.Rwezaula, M.Krag, J.Mghamba, K.Ramaiya, Health policy for sickle cell disease in Africa:experience from Tanzania on interventions to reduce under-five mortality. Trop Med Int Health. 2015;20(2):184–7.
9. J.Makani, A.N.Komba, S.E.Cox, J.Oruo, K.Mwamtemi, J.Kitundu, Malaria in patients with sickle cell anemia:Burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood. 2010;115(2):215–20. doi:10.1182/blood-2009-07-233528
10. F.B.Piel, A.P.Patil, R.E.Howes, O.A.Nyangiri, P.W.Gething, T.N.Williams, Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1:104. doi:10.1038/ncomms1104
11. A.Allison. The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria. Trans R Soc Trop Med Hyg. 1954;48(4):312–8. doi:10.1016/0035-9203(54)90101-7
12. F.M.Gill, L.A.Sleeper, S.J.Weiner, A.K.Brown, R.Bellevue, R.Grover, Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease. Blood. 1995;86(2):776–83.
13. M.N.Aloni, L.Nkee. Challenge of managing sickle cell disease in a pediatric population living in Kinshasa, Democratic republic of Congo:A sickle cell center experience. Hemoglobin. 2014;38(3):196–200. doi:10.3109/03630269.2014.896810
14. A.Gray, E.N.Anionwu, S.C.Davies, M.Brozovic. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol. 1991;44(6):459–63. doi:10.1136/jcp.44.6.459
15. A.N.Thomas, C.Pattison, G.R.Serjeant. Causes of death in sickle-cell disease in Jamaica. Br Med J (Clin Res Ed). 1982;285(6342):633–5. doi:10.1136/bmj.285.6342.633
16. K.Ohene-Frempong, S.J.Weiner, L.A.Sleeper, S.T.Miller, S.Embury, J.W.Moohr, Cerebrovascular accidents in sickle cell disease:rates and risk factors. Blood. 1998;91(1):288–94.
17. Research on Poverty Alleviation (REPOA) & Michigan State University (MSU). Round 5 Afrobarometer Survey in Tanzania; 2012.
18. S.K.Ballas, S.Lieff, L.J.Benjamin, C.D.Dampier, M.M.Heeney, C.Hoppe, Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85(1):6–13.
19. S.A.Adegoke, O.O.Adeodu, A.D.Adekile. Sickle cell disease clinical phenotypes in children from South-Western, Nigeria. Niger J Clin Pract. 2015;18(1):95–101.
20. T.A.A.D.M.Fernandes, T.M.D.de Medeiros, J.J.P.Alves, C.M.Bezerra, J.V.Fernandes, É.S.S.Serafim, Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern Brazil. Rev Bras Hematol Hemoter. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. 2015;37(3):172–7. doi:10.1016/j.bjhh.2015.03.013
21. B.J.Brown, B.F.Akinkunmi, O.J.Fatunde. Age at diagnosis of sickle cell disease in a developing country. Afr J Med Med Sci. 2010;39(3):221–5.
22. L.Lieberman, M.Kirby, L.Ozolins, J.Mosko, J.Friedman. Initial presentation of unscreened children with sickle cell disease:the Toronto experience. Pediatr Blood Cancer. 2009;53(3):397–400. doi:10.1002/pbc.22023
23. A.F.Fleming, J.Storey, L.Molineaux, E.A.Iroko, E.D.Attai. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol. 1979;73(2):161–72.
24. M.C.Rahimy. Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood. 2003;102(3):834–8. doi:10.1182/blood-2002-05-1453
25. E.Yanni, S.D.Grosse, Q.Yang, R.S.Olney. Trends in pediatric sickle cell disease-related mortality in the United States, 1983–2002. J Pediatr. 2009;154:541–5. doi:10.1016/j.jpeds.2008.09.052
26. Y.Teoh, A.Greenway, H.Savoia, P.Monagle, J.Roy, C.Barnes. Hospitalisations for sickle-cell disease in an Australian paediatric population. J Paediatr Child Health. 2013;49(1):68–71. doi:10.1111/jpc.12018
27. M.B.Fosdal, A.W.Wojner-Alexandrov. Events of hospitalization among children with sickle cell disease. J Pediatr Nurs. 2007;22(4):342–6. doi:10.1016/j.pedn.2006.09.001
28. T.N.Williams, S.Uyoga, A.Macharia, C.Ndila, C.F.McAuley, D.H.Opi, Bacteraemia in Kenyan children with sickle-cell anaemia:a retrospective cohort and case–control study. Lancet. 2009;374:1364–70. doi:10.1016/S0140-6736(09)61374-X
29. O.S.Platt, B.D.Thorington, D.J.Brambilla, P.F.Milner, W.F.Rosse, E.Vichinsky, Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11–6. doi:10.1056/NEJM199107043250103
30. O.Castro, D.J.Brambilla, B.Thorington, C.A.Reindorf, R.B.Scott, P.Gillette, The acute chest syndrome in sickle cell disease:incidence and risk factors. The cooperative study of sickle cell disease. Blood. 1994;84(2):643–9.
31. S.E.Cox, J.Makani, A.J.Fulford, A.N.Komba, D.Soka, T.N.Williams, Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania. Haematologica. 2011 Jul;96(7):948–53. doi:10.3324/haematol.2010.028167
32. W.C.Wang, K.Dwan. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Cochrane Database Syst Rev. 2013;11(11):1–31.
33. N.Galadanci, S.Abdullahi, M.Tabari, S.Abubakar, R.Belonwu, A.Salihu, Primary stroke prevention in Nigerian children with sickle cell disease (SPIN):challenges of conducting a feasibility trial. Pediatr Blood Cancer. 2015;62(3):395–401. doi:10.1002/pbc.25289
34. C.Hirst, S.Owusu-Ofori. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev. 2014;11:CD003427.
35. N.B.Halasa, S.M.Shankar, T.R.Talbot, P.G.Arbogast, E.F.Mitchel, W.C.Wang, Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44(11):1428–33. doi:10.1086/516781
36. J.Hassell, J.Makani, S.Punnialingam, L.Smart, D.Soka Management of sickle cell disease. Dar es Salaam. 2014:1–40.
37. S.Charache, M.L.Terrin, R.D.Moore, G.J.Dover, F.B.Barton, S.V.Eckert, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. New Engl J Med. 1995;332(20):1317–22.
38. M.H.Steinberg, F.Barton, O.Castro, C.H.Pegelow, S.K.Ballas, A.Kutlar, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia:risks and benefits up to 9 years of treatment. JAMA. 2003;289(13):1645–51. doi:10.1001/jama.289.13.1645
39. C.D.Thornburg, B.A.Files, Z.Luo, S.T.Miller, R.Kalpatthi, R.Iyer, Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 2012;120:4304–10. doi:10.1182/blood-2012-03-419879
40. P.Pino, Z.Taoufiq, M.Brun, M.Tefit, J.F.Franetich, L.Ciceron, Effects of hydroxyurea on malaria, parasite growth and adhesion in experimental models. Parasite Immunol. 2006;28(12):675–80. doi:10.1111/j.1365-3024.2006.00907.x
41. M.Brun, S.Bourdoulous, P.O.Couraud, J.Elion, R.Krishnamoorthy, C.Lapoumeroulie. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells. Pharmacogenomics J. 2003;3(4):215–26. doi:10.1038/sj.tpj.6500176
42. J.L.Raphael, S.O.Oyeku, M.A.Kowalkowski, B.U.Mueller, A.M.Ellison. Trends in blood transfusion among hospitalized children with sickle cell disease. Pediatr Blood Cancer. 2013;60(11):1753–8. doi:10.1002/pbc.24630
43. R.Simbauranga. Prevalence of anemia and factors associated with severe anemia among under five children admitted at Bugando Medical Centre, Mwanza, Tanzania. Catholic University of Health and Allied Sciences Bugando; 2013.